Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

See the latest Novartis AG ADR stock price (NVS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Novartis AG offers growth potential with a balanced drug portfolio, manageable debt, and shares priced below fair value.

Novartis has filed a lawsuit seeking to block a Maryland law that would require drugmakers to offer discounts on drugs dispensed by third-party pharmacies that contract with hospitals and clinics ...

Novartis carries a solid financial position with a debt/EBITDA ratio of 1.5 times. Further, its diverse portfolio of drugs should translate into steady cash flows to easily service debt requirements.

To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s biggest stages. The drugmaker’s first-ever Super Bowl ad is set to ...

The forum came at time when there appears to be little health messaging at the federal level.

Novartis plans to cut 285 jobs at its U.S. headquarters in East Hanover as part of a restructuring announced earlier this year by the Swiss pharma giant.. According to a notice filed with the New ...

A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug Price Negotiation Program, ruling that the program does not violate ...

Novartis Pharma Services AG donated US$ 200,000 to the King Hussein Cancer Foundation (KHCF) which is dedicated entirely towards the planned expansion o ...

Novartis has entered a 3-year partnership with Schrödinger, a computational chemistry services company, to discover new drugs. Novartis will gain access to Schrödinger’s wide range of drug ...